×
ADVERTISEMENT

AUGUST 19, 2021

Avoiding Rx Delays Amid Oral Chemotherapy Surge

By Gina Shaw

Oral oncolytics are hardly new. Breast cancer patients have been taking tamoxifen for more than 40 years. But the pace of approval of these drugs has increased dramatically, and the complexity and cost of the newer oral therapies create challenges for patients, clinicians and health systems.

Getting patients on treatment with oral oncolytics is not simple. Delays in processing these medications and initiating therapy are common and often related to insurance coverage and prior